Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Edge Therapeutics Inc.
DescriptionSustained-release injectable formulation of nimodipine, a generic calcium channel blocker, consisting of biodegradable microparticles delivered through a patient's existing external ventricular drain
Molecular Target Calcium channel
Mechanism of ActionCalcium channel blocker
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today